InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by BAKER G LEONARD JR, Director. Officer active across 2 companies, notably Corcept Therapeutics INC. In total, 6 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €1.8m. History available since 18 May 2021. The latest transaction was disclosed on 1 January 2025 (Don). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
00Common StockSEC:0001225208-25-000061:0
00Common StockSEC:0001225208-23-007580:0
50,000 shares@ US$21.53100.0% of flowCommon StockSEC:0001225208-21-009444
Ideal exit: 8 Mar 2022 (T+270)
50,000 shares@ US$21.530.015% mcap73.3% of flowCommon StockSEC:0001225208-21-009444:0
Ideal exit: 8 Mar 2022 (T+270)
30,000 shares@ US$6.5513.3% of flowCommon StockSEC:0001225208-21-008372
30,000 shares@ US$6.550.0027% mcap13.3% of flowCommon StockSEC:0001225208-21-008372:0
6 of 6 declarations
About BAKER G LEONARD JR
Leonard G. Baker Jr. is a Director at CORCEPT THERAPEUTICS INC. As a board member, he contributes to the governance of the company and strategic decision-making. Leonard brings valuable expertise in the biotechnology field, helping CORCEPT navigate a complex environment and focus on innovation. His commitment to excellence is an asset to the company.
